|
Dr. Viehman focuses his clinical research in several areas, including drug resistance, antibiotic stewardship, and quality improvement. Currently, he is working on projects evaluating patient risk factors for drug-resistant pathogens, including vancomycin-resistant Enterococcus faecium and adjunctive therapy for patients with C. difficile infection. ln addition, he is evaluating barriers to vaccination against Streptococcus pneumoniae in patients who meet appropriate indications.
|